Skip to Main Content

Paper Details

Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.
Gynecol Oncol
12
2015
FSHB, GNRH, INHA, INHBB, LHCGR, Ovarian cancer, SNPs, breast and prostate cancers, gene, genes, gonadotropin, gonadotropin signaling pathway genes, gonadotropins, high-penetrance susceptibility genes, ovarian cancer
Author NameAffiliation
Jonathan TyrerUniversity of Cambridge
Jennifer A DohertyThe Geisel School of Medicine at Dartmouth
Jennifer A DohertyThe Geisel School of Medicine at Dartmouth
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Peter A FaschingUniversity of California at Los Angeles, David Geffen School of Medicine, USA University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Universitaetsstrasse 21-23
Diether LambrechtsVesalius Research Center
Jenny Chang-ClaudeGerman Cancer Research Center (DKFZ)
Lara E Sucheston-CampbellRoswell Park Cancer Institute
Pamela J ThompsonSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, USA Community and Population Health Research Institute
Marc T GoodmanSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, USA Community and Population Health Research Institute
Lynne R WilkensUniversity of Hawaii Cancer Center
Lynne R WilkensUniversity of Hawaii Cancer Center
Andreas du Bois
Sandra OrsulicWomen's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Jenny LesterWomen's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Beth Y KarlanWomen's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Ellen L GoodeMayo Clinic
Brooke L FridleyUniversity of Kansas Medical Center
Graham G GilesThe University of Melbourne
Douglas A LevineMemorial Sloan Kettering Cancer Center
Douglas A LevineMemorial Sloan Kettering Cancer Center
Joellen M SchildkrautDuke University Medical Center, Duke Cancer Institute
Andrew BerchuckDuke University Medical Center
Elisa V BanderaRutgers Cancer Institute of New Jersey
Lambertus A KiemeneyRadboud University Medical Centre
Katja K H AbenRadboud University Medical Centre, The Netherlands Comprehensive Cancer Center The Netherlands
Yukie BeanOregon Health and Science University, USA Knight Cancer Institute
Tanja PejovicOregon Health and Science University, USA Knight Cancer Institute
Linda E KelemenAlberta Health Services-Cancer Care, University of Calgary
Angela Brooks-WilsonSimon Fraser University
Jan LubinskiPomeranian Medical University
Jan LubinskiPomeranian Medical University
Jacek GronwaldPomeranian Medical University
Jacek GronwaldPomeranian Medical University
Cezary CybulskiPomeranian Medical University
Nicolas WentzensenNational Cancer Institute
Louise A BrintonNational Cancer Institute
Louise A BrintonNational Cancer Institute
Jolanta LissowskaMaria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
Jolanta LissowskaMaria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
Honglin SongUniversity of Cambridge
Ian G CampbellUniversity of Melbourne, Peter MacCallum Cancer Centre
Rosalind GlasspoolCancer Research UK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, University of Glasgow
Iain A McNeishInstitute of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Beatson Institute for Cancer Research
Weiva SiehStanford University School of Medicine
Joseph H RothsteinStanford University School of Medicine
Alice S WhittemoreStanford University School of Medicine
John R McLaughlinLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Hoda Anton-CulverGenetic Epidemiology Research Institute, University of California Irvine
  • 1 - 50

Datasets